21.01.2022

Combination is key

New treatments for lung and colon cancer? weiter

05.01.2022

T-knife Therapeutics Appoints Ronald Krasnow, J.D., as General Counsel

T-knife Therapeutics, Inc., a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer, today announced the appointment of Ronald Krasnow, J.D., who brings over thirty years of legal counsel and executive management experience to T-knife. weiter

03.08.2021

Berlin start-up T-knife raises $110 million

T-knife, a spin-off from the MDC and Charité, has raised 110 million U.S. dollars from international investors. The Berlin-based biotech company is developing novel immunotherapies against cancer that focus on teaching a patient’s T cells to recognize and fight solid tumors. weiter

Colors of BerlinBioCube